Skip to content
★ Sign in to follow
JT

John T. Curnutte

CEO
Portola Pharmaceuticals Inc
Total declarations
61
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (21 ops.)
€7.8M

Latest filing published 21 May 2019 for PORTOLA PHARMACEUTICALS INC.

Filing timeline

BuySale
John T. Curnutte

Insider track record

Disclosed buys
0
Disclosed sells
21
Signal history

John T. Curnutte: trading record in brief

John T. Curnutte appears in our data through filings on Portola Pharmaceuticals Inc shares, published by SEC (Form 4). We count 61 filings; the first trade dates from 16 June 2014 and the latest from 20 May 2019.

Sales make up the whole of the open-market record (21 sales, €7.8M). The rest of the record consists of 21 share grants and 19 option exercises.

The latest filing, published on 21 May 2019, reports a share grant in Portola Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to John T. Curnutte

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations61 total

25 of 61 declarations